Gapping up
In reaction to strong earnings/guidance:
- PBYI +19.7%, SIEN +11.8%, ELY +10.5%, ALRM +10.2%, FNKO +7.9%, WPRT +7.7%, LGF.A +6.1%, YELP +5.9%, EPAY +5.8%, UNIT +5.6%, WPP +5.3%, DPLO +5.3%, FGEN +5.1%, OMER +4.2%, PCTY +3.1%, MTW +3%, VSAT +2.9%, SYMC +2.4% (Symantec confirms sale of its enterprise security business to Broadcom (AVGO) for $10.7 bln in cash), BRFS +2.2%, CHUY +2%, COLD +1.9%, APPN +1.8%, JAG +1.8%, ASYS +1.7%, RBA +1.4%, BGNE +1.1%, IIIV +1%
M&A news:
- GRPN +1.1% (acquires Presence AI; terms not disclosed)
Other news:
- EIDX +15.4% (BridgeBio Pharma (BBIO) affirms 66.7% active stake, delivers letter setting forth non-binding proposal to acquire all remaining shares for a fixed exchange ratio of 1.30 shares of the Reporting Person for each share of the Issuer)
- LXRX +7% (announces publication of "positive" data for Zynquista (Sotagliflozin) on cardiorenal clinical biomarkers in adults with type 1 diabetes)
- DPLO +5.3% (reviewing strategic alternatives)
- AZN +2.2% (Tagrisso significantly improves overall survival in the Phase III FLAURA trial for 1st-line EGFR-mutated non-small cell lung cancer )
- CLVS +2.1% (modestly rebounding; also prices $250 mln of 4.50% convertible senior notes due 2024)
Analyst comments:
- N/A